Zhang ZL - Search Results

1

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers.

Li YC, Li KS, Liu ZL, Tang YC, Hu XQ, Li XY, Shi AD, Zhao LM, Shu LZ, Lian S, Yan ZD, Huang SH, Sheng GL, Song Y, Liu YJ, Huan F, Zhang MH, Zhang ZL. Li YC, et al. Among authors: zhang mh, zhang zl. Front Immunol. 2022 Oct 28;13:1049812. doi: 10.3389/fimmu.2022.1049812. eCollection 2022. Front Immunol. 2022. PMID: 36389727 Free PMC article. Review.

2

Identification of bile survivin and carbohydrate antigen 199 in distinguishing cholangiocarcinoma from benign obstructive jaundice.

Liu Y, Sun J, Zhang Q, Jin B, Zhu M, Zhang Z. Liu Y, et al. Biomark Med. 2017 Jan;11(1):11-18. doi: 10.2217/bmm-2016-0178. Epub 2016 Nov 22. Biomark Med. 2017. PMID: 27874286

3

The distal classification and management of choledochal cyst in adults: Based on the relation between cyst and pancreatic duct.

Liu Y, Sun J, Guo S, Liu Z, Zhu M, Zhang ZL. Liu Y, et al. Among authors: zhang zl. Medicine (Baltimore). 2017 Mar;96(12):e6350. doi: 10.1097/MD.0000000000006350. Medicine (Baltimore). 2017. PMID: 28328818 Free PMC article.

4

Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling.

Xu YF, Liu HD, Liu ZL, Pan C, Yang XQ, Ning SL, Zhang ZL, Guo S, Yu JM. Xu YF, et al. Among authors: zhang zl. J Cell Mol Med. 2018 Nov;22(11):5596-5606. doi: 10.1111/jcmm.13833. Epub 2018 Aug 30. J Cell Mol Med. 2018. PMID: 30160357 Free PMC article.

5

HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium.

Xu YF, Liu ZL, Pan C, Yang XQ, Ning SL, Liu HD, Guo S, Yu JM, Zhang ZL. Xu YF, et al. Among authors: zhang zl. Oncogene. 2019 Feb;38(6):868-880. doi: 10.1038/s41388-018-0485-8. Epub 2018 Sep 3. Oncogene. 2019. PMID: 30177842

6

Transcription factor 7 promotes the progression of perihilar cholangiocarcinoma by inducing the transcription of c-Myc and FOS-like antigen 1.

Liu Z, Sun R, Zhang X, Qiu B, Chen T, Li Z, Xu Y, Zhang Z. Liu Z, et al. EBioMedicine. 2019 Jul;45:181-191. doi: 10.1016/j.ebiom.2019.06.023. Epub 2019 Jun 24. EBioMedicine. 2019. PMID: 31248836 Free PMC article.

7

Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.

Sun R, Liu Z, Qiu B, Chen T, Li Z, Zhang X, Xu Y, Zhang Z. Sun R, et al. EBioMedicine. 2019 Sep;47:142-155. doi: 10.1016/j.ebiom.2019.08.062. Epub 2019 Sep 3. EBioMedicine. 2019. PMID: 31492557 Free PMC article.

8

PTPN3 suppresses the proliferation and correlates with favorable prognosis of perihilar cholangiocarcinoma by inhibiting AKT phosphorylation.

Sun R, Chen T, Li M, Liu Z, Qiu B, Li Z, Xu Y, Pan C, Zhang Z. Sun R, et al. Biomed Pharmacother. 2020 Jan;121:109583. doi: 10.1016/j.biopha.2019.109583. Epub 2019 Nov 6. Biomed Pharmacother. 2020. PMID: 31706106 Free article.

9

Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle.

Qiu B, Chen T, Sun R, Liu Z, Zhang X, Li Z, Xu Y, Zhang Z. Qiu B, et al. EBioMedicine. 2019 Dec;50:166-177. doi: 10.1016/j.ebiom.2019.11.021. Epub 2019 Nov 22. EBioMedicine. 2019. PMID: 31761616 Free PMC article.

10

Downregulation of EVI1 Expression Inhibits Cell Proliferation and Induces Apoptosis in Hilar Cholangiocarcinoma via the PTEN/AKT Signalling Pathway.

Zhang XM, Liu ZL, Qiu B, Xu YF, Pan C, Zhang ZL. Zhang XM, et al. Among authors: zhang zl. J Cancer. 2020 Jan 13;11(6):1412-1423. doi: 10.7150/jca.31903. eCollection 2020. J Cancer. 2020. PMID: 32047548 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,352 results

Search Page